Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Addictive substances and neurological disease : alcohol, tobacco, caffeine, and drugs of abuse in everyday lifestyles / / edited by Ronald Ross Watson, University of Arizona, Arizona Health Sciences Center, Tucson, AZ, USA, Sherma Zibadi, Department of Pathology, University of South Florida Medical School, Tampa, FL, USA
| Addictive substances and neurological disease : alcohol, tobacco, caffeine, and drugs of abuse in everyday lifestyles / / edited by Ronald Ross Watson, University of Arizona, Arizona Health Sciences Center, Tucson, AZ, USA, Sherma Zibadi, Department of Pathology, University of South Florida Medical School, Tampa, FL, USA |
| Pubbl/distr/stampa | London : , : Academic Press, an imprint of Elsevier, , [2017] |
| Descrizione fisica | 1 online resource (xv, 398 pages) : illustrations (chiefly color) |
| Disciplina | 616.8607 |
| Collana | Gale eBooks |
| Soggetto topico |
Substance abuse - Physiological aspects
Substance abuse - Psychological aspects Drugs of abuse - Physiological effect Nervous system - Diseases |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Acute ethanol-induced changes in microstructural and metabolite concentrations on the brain: noninvasive functional brain Imaging -- Prenatal alcohol exposure and neuroglial changes in neurochemistry and behavior in animal models -- Alcohol on histaminergic neurons of brain -- Antenatal alcohol and histological brain disturbances -- Alcohol intoxication and traumatic spinal cord injury: basic and clinical science -- Visual and auditory changes after acute alcohol ingestion -- Zebrafish models of alcohol addiction -- Effect of alcohol on the regulation of a-Synuclein in the human brain -- Consumption of ethanol and tissue changes in the central nervous system -- Ethanol consumption and cerebellar disorders -- Gene expression in CNS regions of genetic rat models of alcohol abuse -- Role of TLR4 in the ethanol-induced modulation of the autophagy pathway in the brain --Cholinergic signaling in ethanol reward -- Alcoholic neurological syndromes -- Frontal lobe dysfunction after developmental alcohol exposure: implications from animal models -- Ethanol's action mechanisms in the brain: from lipid general alterations to specific protein receptor binding -- Antioxidant vitamins and brain dysfunction in alcoholics -- Serotonin deficiency and alcohol use disorders -- Functional reorganization of reward- and habit-related brain networks in addiction -- Ethanol: neurotoxicity and brain disorders -- Functionally relevant brain alterations in polysubstance users: differences to monosubstance users, study challenges, and implications for treatment -- Deep brain stimulation: a possible therapeutic technique for treating refractory alcohol and drug addiction behaviors -- Understanding the roles of genetic and environmental influences on the neurobiology of nicotine use -- Tobacco smoke and nicotine: neurotoxicity in brain development -- Paradise lost: a new paradigm for explaining the interaction between neural and psychological changes in nicotine addiction patients -- Interactions of alcohol and nicotine: CNS sites and contributions to their co-abuse -- Role of basal forebrain in nicotine alcohol co-abuse -- Chronic and acute nicotine exposure versus placebo in smokers and nonsmokers: a systematic review of resting-state fMRI studies -- Novel psychoactive substances: a new behavioral and mental health threat -- Cholesterol and caffeine modulate alcohol actions on cerebral arteries and brain -- Sleep, caffeine, and physical activity in older adults -- Ketamine: neurotoxicity and neurobehavioral disorders -- Left/right hemispheric "unbalance" model in addiction. |
| Record Nr. | UNINA-9910583095403321 |
| London : , : Academic Press, an imprint of Elsevier, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | xxv, 654 p. : ill. (some col.) |
| Disciplina | 616/.0473 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Arthritis - Nutritional aspects
Inflammation Bioactive compounds |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795189703321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for arthritis and related inflammatory diseases / / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for arthritis and related inflammatory diseases / / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | xxv, 654 p. : ill. (some col.) |
| Disciplina | 616/.0473 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Arthritis - Nutritional aspects
Inflammation Bioactive compounds |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- Acknowledgments for Bioactive Foods in Chronic Disease States -- Bioactive Food as Interventions for Arthritis and Related Inflammatory Diseases -- Copyright -- Contents -- Preface: Arthritis and Inflammation -- Contributors -- Chapter 1: Antioxidant Flavonoids for Arthritis Treatment: Human and Animal Models -- Abbreviations -- 1.Introduction to Phytoflavonoids -- 2.What Is Arthritis? -- 3.Osteoarthritis -- 4.Rheumatoid Arthritis -- 5.Flavonoids -- 6.Animal Models of Acute and Chronic Inflammation -- 7.Flavonoids and Its Effect on Animal Model Arthritis -- 8.Radiographic Analysis of Adjuvant-Induced Arthritis -- 9.Flavonoids Devoid of Toxic Effects -- 10.Clinical Trial of Flavonoids on Arthritis -- 11.The Mechanism of Actions of Flavonoids -- Acknowledgment -- References -- Chapter 2: Inflammation in Arthritis -- Abbreviations -- 1.Introduction -- 2.Mechanism of Inflammation in Arthritis -- 3.Dairy Products and Inflammation -- 4.Effects of Food and Spices in Inflammation -- 5.The Role of PUFA in Arthritis -- 6.Antioxidants and Inflammation in Arthritis -- 7.Summary -- References -- Chapter 3: Effects of Beef on Inflammation Affecting Arthritis -- Abbreviations -- 1. Introduction -- 1.1. Arthritis -- 1.1.1. Overview -- 1.1.2. Prevalence -- 1.1.3. Disability -- 1.1.4. Treatment -- 1.2. Beef -- 1.2.1. Overview -- 1.2.2. Nutrients -- 1.2.2.1.1. Polyunsaturated Fatty Acids -- 1.2.2.1.2. Monounsaturated Fatty Acids -- 1.2.2.1.3. Saturated Fatty Acids -- 1.2.2.1.4. Cholesterol -- 2. Arthritis and Diet -- 2.1. Osteoarthritis -- 2.1.1. Overview -- 2.1.2. Prevention -- 2.1.3. Treatment -- 2.1.4. Discussion -- 2.2. Rheumatoid Arthritis -- 2.2.1. Overview -- 2.2.2. Nutrition status -- 2.2.3. Prevention -- 2.2.4. Foods associated with symptom aggravation -- 2.2.5. Treatment -- 2.2.5.2.1. PUFAs -- 2.2.5.2.2. MUFAs -- 2.2.5.2.3. Protein.
2.2.6. Discussion -- 2.3. Gout -- 2.3.1. Overview -- 2.3.2. Prevention -- 2.3.3. Treatment -- 2.3.4. Discussion -- 3. Contraindications of Beef -- 3.1. Cancer -- 3.2. Heart Disease -- 4. Dietary Recommendations of Beef -- 5. Conclusions -- Definitions -- References -- Further Reading -- Chapter 4: Contribution of Bioactive Foods and Their Emerging Role in Immunomodulation, Inflammation, and Arthritis -- Abbreviations -- 1. Bioactive Food Components -- 2. Immunomodulation -- 2.1. Flavan-3-ols -- 2.2. Isoflavones -- 2.3. Flavones, Flavonols, and Relevant Nonflavonoid Polyphenols -- 2.4. Chalcones -- 3. Arthritis -- 3.1. Flavan-3-ols -- 3.2. Flavones, Flavanones, Isoflavones, and Flavonols -- 3.3. Anthocyanins -- 4. Inflammation -- 4.1. Flavan-3-ols -- 4.2. Isoflavones -- 4.3. Flavones, Flavanones, and Flavonols -- 4.4. Anthocyanins -- References -- Chapter 5: Curcumin and Joint Health: From Traditional Knowledge to Clinical Validation -- Abbreviations -- 1. Introduction -- 2. Clinical Relevance of Osteoarthritis -- 3. Prevalence and Causes of OA -- 4. Current OA Treatments -- 5. Preclinical and Clinical Evidence of Activity for Curcumin in the Treatment of OA -- 6. The Bioavailability Issue -- 7. The Development of a Novel Curcumin-Phospholipid Complex (Meriva) -- 8. Clinical Efficacy of Curcumin and of Meriva in the Management of Osteoarthrosis -- 9. Conclusions -- References -- Chapter 6: Dried Plum and Bone Health -- Abbreviations -- 1. Introduction -- 2. Plant-Based Foods and Bone Health -- 3. Bone Remodeling -- 4. Role of Inflammation in Bone Loss -- 5. Oxidative Stress and Bone -- 6. Dried Plums -- 7. Dried Plums Prevent Bone Loss -- 8. Dried Plum Restores Bone -- 9. Clinical Studies, Dried Plum and Bone -- 10. Dried Plum, Bone and Inflammation -- 11. Conclusions -- Glossary -- References -- Further Reading -- Relevant Websites. Chapter 7: The Alkaline Way: Integrative Management of Rheumatoid Arthritis and Other Autoimmune Conditions -- 1. An Integrative Approach -- 1.1. Evaluating Markers of Inflammation, Detoxification, and Immune Function -- 1.2. Testing for Delayed Antigen Reactions to Food and Chemicals -- 1.2.1. Antibody assays -- 1.2.2. Immune complexes -- 1.2.3. Lymphocyte response assays -- 1.2.4. Comparative methodology -- 1.2.5. Accuracy of functional immunology tests -- 2. Restoring Alkaline Balance -- 2.1. The Alkaline Diet -- 2.1.1. The importance of reducing acidity in the body -- 2.1.2. Reducing inflammation -- 2.1.3. Increasing nutrient levels -- 2.1.4. Improving health, functionality, and symptoms -- 2.1.5. Enhancing immune defenses -- 2.2. Alkaline Nutrients -- 2.3. Self-Testing for Alkaline Status -- 3. Self-Care -- 3.1. Physical Fitness and Immune Competence -- 3.2. Mindfulness Practice and Immunity -- 4. Discussion -- 5. Conclusions -- References -- Relevant Websites -- Chapter 8: Marine Omega-3 Polyunsaturated Fatty Acids and Rheumatoid Arthritis -- Abbreviations -- 1. Introduction -- 2. Rheumatoid Arthritis -- 3. Arachidonic Acid, Eicosanoids and the Links with Inflammation and RA -- 4. Fatty Acid Modification of Immune Cell Fatty Acid Composition and of Eicosanoid Profiles -- 5. Resolvins: Novel Anti-Inflammatory and Inflammation-Resolving Mediators Produced from EPA and DHA -- 6. Influence of Marine n-3 Fatty Acids on Inflammatory Cytokines -- 6.1. Transcription Factors Involved in Regulating Inflammatory Gene Expression -- 6.2. Fatty Acid Modulation of Transcription Factor Activation and Inflammatory Cytokine Production -- 7. Influence of Marine n-3 Fatty Acids on T Cells -- 8. Influence of Marine n-3 Fatty Acids on Antigen Presentation -- 9. Marine n-3 PUFAs and Animal Models of RA -- 10. Trials of Marine n-3 PUFAs in RA. 10.1. Summary of Trials -- 10.2. Meta-Analyses -- 11. Overall Conclusions -- References -- Chapter 9: Diet Modulated Inflammation in Chronic Disease: An Overview -- 1. Introduction -- 2. Measuring Metaflammation -- 3. Nutrition and Metaflammation -- 3.1. Total Energy Intake -- 3.2. Dietary Patterns -- 3.3. Macronutrients -- 3.3.1. Dietary fats -- 3.3.2. Carbohydrates -- 3.4. Micronutrients -- 3.5. Beverages -- 4. Summary -- References -- Chapter 10: Food Supplements and Immune Function in Humans -- Abbreviations -- 1. Introduction: Nutrition and Immunity -- 1.1. The Immune System -- 1.2. Immune-Related Diseases -- 1.3. Relationships Between Nutrition and Immunity -- 2. Food Supplementation and Disease -- 2.1. Respiratory Diseases: Bronchitis, Asthma, Rhinitis -- 2.2. Food Allergies -- 2.3. Celiac Disease -- 2.4. Inflammatory Bowel Disease/Crohn's Disease -- 2.5. Atopic Dermatitis and Eczema -- 2.6. Psoriasis -- 2.7. Systemic Lupus Erythematosus -- 2.8. Rheumatoid Arthritis -- 2.9. Multiple Sclerosis -- 2.10. Cognitive Degeneration and Alzheimer's Disease -- 3. Conclusion -- Glossary -- References -- Further reading -- Chapter 11: Natural Antioxidants and Resistance to Infection -- Abbreviations -- 1. Introduction -- 2. Oxidative Stress and Antioxidant Protection -- 3. Vitamins and Host Resistance to Infection -- 3.1. Vitamin A and β-Carotene -- 3.2. Vitamin C -- 3.3. Vitamin E -- 4. Trace Elements and Host Resistance to Infection -- 4.1. Selenium -- 4.2. Iron -- 4.3. Zinc -- 4.4. Copper -- 5. Summary Points -- References -- Chapter 12: The Effects of Flavonoids on the Immune System -- Abbreviations -- 1. Introduction -- 2. Acquired Immunity: The Tailored Response Against Antigen -- 3. Flavonoids in the Immune System -- 3.1. In Vitro Studies of Flavonoids in the Immune System. 3.2. The Effect of Flavonoid Intake on the Functionality of the Immune System -- 3.2.1. Preclinical studies with single flavonoids administered orally -- 3.2.2. Preclinical studies using food extracts rich in flavonoids -- 3.2.3. Clinical studies using food or extracts rich in flavonoids -- 4. Concluding Remarks -- Glossary -- References -- Further Reading -- Chapter 13: Wheat Allergy -- Abbreviations -- 1. Allergy to Wheat and Related Diseases -- 2. Changes in Allergenic Properties of Wheat Induced by Heat and Industrial Processing -- 3. Allergen Cross-Reactivity Among Cereals, Pollen, and Other Vegetal Foods -- 4. Why Patients with Baker's Asthma Due to Wheat Tolerate Wheat Flour Ingestion? -- 5. Relationship Between Diet and Allergic Asthma -- 6. The Role of Wheat in Diabetic's Diet -- 7. Cereal Tolerance Mechanism and Treatment Possibilities -- References -- Chapter 14: Tomato Food Allergy -- Abbreviations -- 1. Food Allergy: Mechanisms, Symptoms, and Prevalence -- 2. Tomato Allergy: Prevalence and Symptoms -- 3. Tomato Allergens -- 3.1. Lyc e 1 -- 3.2. Lyc e 2 -- 3.3. Lyc e 3 -- 3.4. Lyc e 4 -- 4. Cross-reactions Among Tomato and Other Allergens -- 4.1. Pollen-Tomato Cross-reactivity -- 4.2. Latex-Pollen-Tomato Cross-reactivity -- 5. Conclusions -- Glossary -- References -- Further Reading -- Relevant Websites -- Chapter 15: Indian Medicinal Plants as Immunomodulators: Scientific Validation of the Ethnomedicinal Beliefs -- Abbreviations -- 1. Introduction -- 2. Plants as Immunomodulators -- 2.1. Ocimum sanctum Linn. or Ocimum tenuiflorum L. (Family Lamiaceae) -- 2.2. Phyllanthus emblica L. or Emblica officinalis Gaertn. (Family Phyllanthaceae) -- 2.3. Withania somnifera (L.) Dunal (Family Solanaceae) -- 2.4. Tinospora cordifolia (Thunb.) Miers (Family Menispermaceae) -- 2.5. Semecarpus anacardium Linn. (Family: Anacardiaceae). 2.6. Azadirachta indica A. Juss (Family Meliaceae). |
| Record Nr. | UNINA-9910808812803321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (722 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Cardiovascular system - Diseases - Nutritional aspects
Bioactive compounds |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-71650-X
0-12-396540-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Matter; Bioactive Food as Dietary Interventions for CardiovascularDisease; Copyright; Contents; Preface: Bioactive Food for Cardiovascular Disease; Contributors; Chapter 1: Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Intervention Trials, Healthy Heart Conce...; 1. Introduction; 2. Role of Omega-3 Fatty Acids in CVD; 2.1. Role of Omega Fatty Acids in Dietary Fat and Vascular Health; 2.2. Role of Omega-3 Fatty Acids in CVD Prevention; 2.3. Therapeutic Lifestyle Changes Diet: A Multifaceted Lifestyle Approach to Reduce Risk of CHD
2.4. Omega-Fatty-Acid-Rich Functional Foods and CVD Risk2.5. Cardioprotective Effects of Omega-3 Fatty Acids; 2.6. Who Needs Initial Treatment with Omega-3 Fatty Acid Supplementation?; 2.7. Safety and Efficacy of Omega Fatty Acid Therapy in Infants, Children, and Adolescents; 3. Modern View of Omega Fatty Acid Therapy in CVD; 3.1. National Guidelines; 3.2. Mechanisms; 3.3. Clinical Trials to Modify Residual Cardiovascular Risk by LDL Cholesterol Lowering; 3.3.1. Saturated fatty acids; 3.3.2. Trans fatty acids; 3.3.3. Dietary cholesterol; 3.3.4. Monounsaturated fatty acids; 3.3.5. Wild foods 3.3.6. Supplementation of omega-3 fatty acids in combinatorial therapy4. Healthy Heart Concept: Less-Known Facts on Omega Fatty Acids; 4.1. Ancient Tribals: Indian Kurichiyas; 4.2. Australian Tribals; 4.3. Greenlandic Eskimos; 4.4. Dietary Fat Intake and Fatty Acid Ratio; 4.4.1. Columbus concept; 4.4.2. Oxidative stress and fatty acid ratio; 5. Guidelines on Omega Fatty Acid in CVD to Physicians, Nurses: Healthy Heart Concept; 5.1. Omega Fatty Acids in CHD: Treating Beyond LDL-C; 6. Implications and Futuristic Prospective; 7. Conclusions; Acknowledgments; References Chapter 2: Herbal Supplements or Herbs in Heart Disease: History, Herbal Foods, Coronary Heart Disease1. Introduction; 1.1. Symptoms of Coronary Heart Disease; 1.2. Biochemical Basis of CHD; 1.2.1. Acute ischemic heart disease; 1.2.2. Congestive heart failure; 1.3. Diagnosis of CHD; 1.3.1. Acute coronary syndrome; 1.3.2. Congestive heart failure; 1.4. Scientific Basis of Herbal Therapy of Heart Disease; 1.4.1. Herbal supplements that open blood vessels; 1.4.2. Supplements that strengthen the heart muscle; 1.4.3. Heart disease and dietary supplements: antioxidants 1.4.4. Chinese herbs in reduction of HDL catabolism2. Relation to TG Metabolism; 3. Herbal Foods: Approved Herbs in Cardiovascular Disease; 3.1. Garlic: The Most-Studied Herbal Food for the Cardiovascular System; 3.2. Hawthorn, Gentle Heart Herb; 3.3. Lemon and Soy, Isoflavanoids; 3.4. Scutellaria, Panacea; 3.5. Radix Salviae Miltiorrhizae, Danshen Herbal Extract; 4. Repertory of Herbs and Their Properties; 5. Herbs in Human Use; 6. Cardioprotective Herb Active Components in Human Use Approved by CDC and Regulated by FDA; 6.1. Biochemical Basis of Herbiceuticals in Cardiac Prevention 7. Conclusion |
| Record Nr. | UNINA-9910462209603321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (722 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Cardiovascular system - Diseases - Nutritional aspects
Bioactive compounds |
| ISBN |
1-283-71650-X
0-12-396540-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Matter; Bioactive Food as Dietary Interventions for CardiovascularDisease; Copyright; Contents; Preface: Bioactive Food for Cardiovascular Disease; Contributors; Chapter 1: Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Intervention Trials, Healthy Heart Conce...; 1. Introduction; 2. Role of Omega-3 Fatty Acids in CVD; 2.1. Role of Omega Fatty Acids in Dietary Fat and Vascular Health; 2.2. Role of Omega-3 Fatty Acids in CVD Prevention; 2.3. Therapeutic Lifestyle Changes Diet: A Multifaceted Lifestyle Approach to Reduce Risk of CHD
2.4. Omega-Fatty-Acid-Rich Functional Foods and CVD Risk2.5. Cardioprotective Effects of Omega-3 Fatty Acids; 2.6. Who Needs Initial Treatment with Omega-3 Fatty Acid Supplementation?; 2.7. Safety and Efficacy of Omega Fatty Acid Therapy in Infants, Children, and Adolescents; 3. Modern View of Omega Fatty Acid Therapy in CVD; 3.1. National Guidelines; 3.2. Mechanisms; 3.3. Clinical Trials to Modify Residual Cardiovascular Risk by LDL Cholesterol Lowering; 3.3.1. Saturated fatty acids; 3.3.2. Trans fatty acids; 3.3.3. Dietary cholesterol; 3.3.4. Monounsaturated fatty acids; 3.3.5. Wild foods 3.3.6. Supplementation of omega-3 fatty acids in combinatorial therapy4. Healthy Heart Concept: Less-Known Facts on Omega Fatty Acids; 4.1. Ancient Tribals: Indian Kurichiyas; 4.2. Australian Tribals; 4.3. Greenlandic Eskimos; 4.4. Dietary Fat Intake and Fatty Acid Ratio; 4.4.1. Columbus concept; 4.4.2. Oxidative stress and fatty acid ratio; 5. Guidelines on Omega Fatty Acid in CVD to Physicians, Nurses: Healthy Heart Concept; 5.1. Omega Fatty Acids in CHD: Treating Beyond LDL-C; 6. Implications and Futuristic Prospective; 7. Conclusions; Acknowledgments; References Chapter 2: Herbal Supplements or Herbs in Heart Disease: History, Herbal Foods, Coronary Heart Disease1. Introduction; 1.1. Symptoms of Coronary Heart Disease; 1.2. Biochemical Basis of CHD; 1.2.1. Acute ischemic heart disease; 1.2.2. Congestive heart failure; 1.3. Diagnosis of CHD; 1.3.1. Acute coronary syndrome; 1.3.2. Congestive heart failure; 1.4. Scientific Basis of Herbal Therapy of Heart Disease; 1.4.1. Herbal supplements that open blood vessels; 1.4.2. Supplements that strengthen the heart muscle; 1.4.3. Heart disease and dietary supplements: antioxidants 1.4.4. Chinese herbs in reduction of HDL catabolism2. Relation to TG Metabolism; 3. Herbal Foods: Approved Herbs in Cardiovascular Disease; 3.1. Garlic: The Most-Studied Herbal Food for the Cardiovascular System; 3.2. Hawthorn, Gentle Heart Herb; 3.3. Lemon and Soy, Isoflavanoids; 3.4. Scutellaria, Panacea; 3.5. Radix Salviae Miltiorrhizae, Danshen Herbal Extract; 4. Repertory of Herbs and Their Properties; 5. Herbs in Human Use; 6. Cardioprotective Herb Active Components in Human Use Approved by CDC and Regulated by FDA; 6.1. Biochemical Basis of Herbiceuticals in Cardiac Prevention 7. Conclusion |
| Record Nr. | UNINA-9910785961103321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (722 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Cardiovascular system - Diseases - Nutritional aspects
Bioactive compounds |
| ISBN |
1-283-71650-X
0-12-396540-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Matter; Bioactive Food as Dietary Interventions for CardiovascularDisease; Copyright; Contents; Preface: Bioactive Food for Cardiovascular Disease; Contributors; Chapter 1: Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Intervention Trials, Healthy Heart Conce...; 1. Introduction; 2. Role of Omega-3 Fatty Acids in CVD; 2.1. Role of Omega Fatty Acids in Dietary Fat and Vascular Health; 2.2. Role of Omega-3 Fatty Acids in CVD Prevention; 2.3. Therapeutic Lifestyle Changes Diet: A Multifaceted Lifestyle Approach to Reduce Risk of CHD
2.4. Omega-Fatty-Acid-Rich Functional Foods and CVD Risk2.5. Cardioprotective Effects of Omega-3 Fatty Acids; 2.6. Who Needs Initial Treatment with Omega-3 Fatty Acid Supplementation?; 2.7. Safety and Efficacy of Omega Fatty Acid Therapy in Infants, Children, and Adolescents; 3. Modern View of Omega Fatty Acid Therapy in CVD; 3.1. National Guidelines; 3.2. Mechanisms; 3.3. Clinical Trials to Modify Residual Cardiovascular Risk by LDL Cholesterol Lowering; 3.3.1. Saturated fatty acids; 3.3.2. Trans fatty acids; 3.3.3. Dietary cholesterol; 3.3.4. Monounsaturated fatty acids; 3.3.5. Wild foods 3.3.6. Supplementation of omega-3 fatty acids in combinatorial therapy4. Healthy Heart Concept: Less-Known Facts on Omega Fatty Acids; 4.1. Ancient Tribals: Indian Kurichiyas; 4.2. Australian Tribals; 4.3. Greenlandic Eskimos; 4.4. Dietary Fat Intake and Fatty Acid Ratio; 4.4.1. Columbus concept; 4.4.2. Oxidative stress and fatty acid ratio; 5. Guidelines on Omega Fatty Acid in CVD to Physicians, Nurses: Healthy Heart Concept; 5.1. Omega Fatty Acids in CHD: Treating Beyond LDL-C; 6. Implications and Futuristic Prospective; 7. Conclusions; Acknowledgments; References Chapter 2: Herbal Supplements or Herbs in Heart Disease: History, Herbal Foods, Coronary Heart Disease1. Introduction; 1.1. Symptoms of Coronary Heart Disease; 1.2. Biochemical Basis of CHD; 1.2.1. Acute ischemic heart disease; 1.2.2. Congestive heart failure; 1.3. Diagnosis of CHD; 1.3.1. Acute coronary syndrome; 1.3.2. Congestive heart failure; 1.4. Scientific Basis of Herbal Therapy of Heart Disease; 1.4.1. Herbal supplements that open blood vessels; 1.4.2. Supplements that strengthen the heart muscle; 1.4.3. Heart disease and dietary supplements: antioxidants 1.4.4. Chinese herbs in reduction of HDL catabolism2. Relation to TG Metabolism; 3. Herbal Foods: Approved Herbs in Cardiovascular Disease; 3.1. Garlic: The Most-Studied Herbal Food for the Cardiovascular System; 3.2. Hawthorn, Gentle Heart Herb; 3.3. Lemon and Soy, Isoflavanoids; 3.4. Scutellaria, Panacea; 3.5. Radix Salviae Miltiorrhizae, Danshen Herbal Extract; 4. Repertory of Herbs and Their Properties; 5. Herbs in Human Use; 6. Cardioprotective Herb Active Components in Human Use Approved by CDC and Regulated by FDA; 6.1. Biochemical Basis of Herbiceuticals in Cardiac Prevention 7. Conclusion |
| Record Nr. | UNINA-9910826169503321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (659 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Diabetes - Nutritional aspects
Bioactive compounds |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-71647-X
0-12-397762-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Bioactive Food as Dietary Interventions for Diabetes; Copyright; Contents; Preface: Diabetes Food; Contributors; Chapter 1: Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; 1. Introduction; 2. Systemic Glucose Homeostasis is a Multiorgan Process; 3. Glucose Dysregulation: The Pathogenesis of Insulin Resistance; 4. Origins of Oxidative Stress in Various Cell Types; 4.1. Renin-Angiotensin System and NADPH Oxidase; 4.2. Nutrient Excess and Mitochondrial Overactivity; 4.3. Hyperglycemia; 4.4. Dyslipidemia: Role of Excess FFAs
4.5. Endoplasmic Reticulum Stress4.6. Additional Role of Nitrosative Stress; 5. Mechanisms of Oxidative Stress-Associated Insulin Resistance; 5.1. Oxidative Stress and Defects in Insulin Signaling: Skeletal Muscle and Liver; 5.2. Oxidative Stress and Defects in Insulin Secretion: Pancreatic Beta-Cells; 5.3. Oxidative Stress and Defects in Vascular Function; 6. Utility of Select Antioxidants as Interventions in Oxidative Stress-Associated Insulin Resistance; 6.1. General Concepts of Antioxidant Properties; 6.2. ALA and Its Effects on Glucoregulation; 7. Conclusion and Perspectives AcknowledgmentsReferences; Relevant Websites; Chapter 2: Diabetes and the Role of Dietary Supplements; 1. Introduction; 2. Alpha-Lipoic Acid; 3. Omega-3 Oils; 4. Chromium; 5. Gymnemma Sylvestre; 6. Fenugreek; 7. Vitamin D; 8. Conclusion; Glossary; References; Chapter 3: Government Regulation of Dietary Supplements and Foods: Role in Diabetes; 1. Introduction; 2. Nongovernmental Recommendations for Diabetics; 3. NHPs for Diabetics; 4. Food Label Information and Nutrition - Health Claims; 5. Nutrition Recommendations for Diabetics; 6. Conclusions; References Chapter 4: Diabetes as an Immune Dysfunction Syndrome1. Diagnostic Laboratory Testing; 1.1. First-Line Assessments; 1.1.1. Glucose and insulin levels; 1.1.2. HbA1c; 1.2. Additional Testing; 1.2.1. C-octanoic acid breath test; 1.2.2. C-peptide; 1.2.3. C-reactive protein (hsCRP); 1.2.4. Cortisol and DHEA; 1.2.5. Lymphocyte Response Assay (LRA) tests; 1.2.6. Fibrinogen; 1.2.7. Homocysteine; 1.2.8. Insulin-like growth factor binding protein-1; 1.2.9. Intestinal hyperpermeability test; 1.2.10. Iron and ferritin; 1.2.11. Oxidized LDL (oxLDL); 1.2.12. Metabolic acidosis risk 1.2.13. Sleep survey or evaluation2. Key Clinical Issues; 2.1. Energy Metabolism; 2.1.1. Glucose; 2.1.2. Fructose; 2.1.3. Protein metabolism in diabetes; 2.1.4. Fat metabolism; 2.2. Autonomic Neuropathy; 2.3. Immune Dysregulation and Increased Permeability; 2.4. Maldigestion; 2.4.1. Reflux; 2.4.2. Dyspepsia; 2.4.3. Dysbiosis; 2.4.4. Malabsorption; 2.4.5. Delayed gastric emptying; 2.5. Autacoids: Profound Biochemical Effects; 3. Diagnoses and Comorbidities; 3.1. Prevalent Comorbidities; 3.1.1. Vascular sequella and neurodegeneration; 3.1.2. Hyperlipidemia and hypertension 3.1.3. Kidney disease |
| Record Nr. | UNINA-9910462229203321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (659 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Diabetes - Nutritional aspects
Bioactive compounds |
| ISBN |
1-283-71647-X
0-12-397762-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Bioactive Food as Dietary Interventions for Diabetes; Copyright; Contents; Preface: Diabetes Food; Contributors; Chapter 1: Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; 1. Introduction; 2. Systemic Glucose Homeostasis is a Multiorgan Process; 3. Glucose Dysregulation: The Pathogenesis of Insulin Resistance; 4. Origins of Oxidative Stress in Various Cell Types; 4.1. Renin-Angiotensin System and NADPH Oxidase; 4.2. Nutrient Excess and Mitochondrial Overactivity; 4.3. Hyperglycemia; 4.4. Dyslipidemia: Role of Excess FFAs
4.5. Endoplasmic Reticulum Stress4.6. Additional Role of Nitrosative Stress; 5. Mechanisms of Oxidative Stress-Associated Insulin Resistance; 5.1. Oxidative Stress and Defects in Insulin Signaling: Skeletal Muscle and Liver; 5.2. Oxidative Stress and Defects in Insulin Secretion: Pancreatic Beta-Cells; 5.3. Oxidative Stress and Defects in Vascular Function; 6. Utility of Select Antioxidants as Interventions in Oxidative Stress-Associated Insulin Resistance; 6.1. General Concepts of Antioxidant Properties; 6.2. ALA and Its Effects on Glucoregulation; 7. Conclusion and Perspectives AcknowledgmentsReferences; Relevant Websites; Chapter 2: Diabetes and the Role of Dietary Supplements; 1. Introduction; 2. Alpha-Lipoic Acid; 3. Omega-3 Oils; 4. Chromium; 5. Gymnemma Sylvestre; 6. Fenugreek; 7. Vitamin D; 8. Conclusion; Glossary; References; Chapter 3: Government Regulation of Dietary Supplements and Foods: Role in Diabetes; 1. Introduction; 2. Nongovernmental Recommendations for Diabetics; 3. NHPs for Diabetics; 4. Food Label Information and Nutrition - Health Claims; 5. Nutrition Recommendations for Diabetics; 6. Conclusions; References Chapter 4: Diabetes as an Immune Dysfunction Syndrome1. Diagnostic Laboratory Testing; 1.1. First-Line Assessments; 1.1.1. Glucose and insulin levels; 1.1.2. HbA1c; 1.2. Additional Testing; 1.2.1. C-octanoic acid breath test; 1.2.2. C-peptide; 1.2.3. C-reactive protein (hsCRP); 1.2.4. Cortisol and DHEA; 1.2.5. Lymphocyte Response Assay (LRA) tests; 1.2.6. Fibrinogen; 1.2.7. Homocysteine; 1.2.8. Insulin-like growth factor binding protein-1; 1.2.9. Intestinal hyperpermeability test; 1.2.10. Iron and ferritin; 1.2.11. Oxidized LDL (oxLDL); 1.2.12. Metabolic acidosis risk 1.2.13. Sleep survey or evaluation2. Key Clinical Issues; 2.1. Energy Metabolism; 2.1.1. Glucose; 2.1.2. Fructose; 2.1.3. Protein metabolism in diabetes; 2.1.4. Fat metabolism; 2.2. Autonomic Neuropathy; 2.3. Immune Dysregulation and Increased Permeability; 2.4. Maldigestion; 2.4.1. Reflux; 2.4.2. Dyspepsia; 2.4.3. Dysbiosis; 2.4.4. Malabsorption; 2.4.5. Delayed gastric emptying; 2.5. Autacoids: Profound Biochemical Effects; 3. Diagnoses and Comorbidities; 3.1. Prevalent Comorbidities; 3.1.1. Vascular sequella and neurodegeneration; 3.1.2. Hyperlipidemia and hypertension 3.1.3. Kidney disease |
| Record Nr. | UNINA-9910785961003321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (659 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Diabetes - Nutritional aspects
Bioactive compounds |
| ISBN |
1-283-71647-X
0-12-397762-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Bioactive Food as Dietary Interventions for Diabetes; Copyright; Contents; Preface: Diabetes Food; Contributors; Chapter 1: Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; 1. Introduction; 2. Systemic Glucose Homeostasis is a Multiorgan Process; 3. Glucose Dysregulation: The Pathogenesis of Insulin Resistance; 4. Origins of Oxidative Stress in Various Cell Types; 4.1. Renin-Angiotensin System and NADPH Oxidase; 4.2. Nutrient Excess and Mitochondrial Overactivity; 4.3. Hyperglycemia; 4.4. Dyslipidemia: Role of Excess FFAs
4.5. Endoplasmic Reticulum Stress4.6. Additional Role of Nitrosative Stress; 5. Mechanisms of Oxidative Stress-Associated Insulin Resistance; 5.1. Oxidative Stress and Defects in Insulin Signaling: Skeletal Muscle and Liver; 5.2. Oxidative Stress and Defects in Insulin Secretion: Pancreatic Beta-Cells; 5.3. Oxidative Stress and Defects in Vascular Function; 6. Utility of Select Antioxidants as Interventions in Oxidative Stress-Associated Insulin Resistance; 6.1. General Concepts of Antioxidant Properties; 6.2. ALA and Its Effects on Glucoregulation; 7. Conclusion and Perspectives AcknowledgmentsReferences; Relevant Websites; Chapter 2: Diabetes and the Role of Dietary Supplements; 1. Introduction; 2. Alpha-Lipoic Acid; 3. Omega-3 Oils; 4. Chromium; 5. Gymnemma Sylvestre; 6. Fenugreek; 7. Vitamin D; 8. Conclusion; Glossary; References; Chapter 3: Government Regulation of Dietary Supplements and Foods: Role in Diabetes; 1. Introduction; 2. Nongovernmental Recommendations for Diabetics; 3. NHPs for Diabetics; 4. Food Label Information and Nutrition - Health Claims; 5. Nutrition Recommendations for Diabetics; 6. Conclusions; References Chapter 4: Diabetes as an Immune Dysfunction Syndrome1. Diagnostic Laboratory Testing; 1.1. First-Line Assessments; 1.1.1. Glucose and insulin levels; 1.1.2. HbA1c; 1.2. Additional Testing; 1.2.1. C-octanoic acid breath test; 1.2.2. C-peptide; 1.2.3. C-reactive protein (hsCRP); 1.2.4. Cortisol and DHEA; 1.2.5. Lymphocyte Response Assay (LRA) tests; 1.2.6. Fibrinogen; 1.2.7. Homocysteine; 1.2.8. Insulin-like growth factor binding protein-1; 1.2.9. Intestinal hyperpermeability test; 1.2.10. Iron and ferritin; 1.2.11. Oxidized LDL (oxLDL); 1.2.12. Metabolic acidosis risk 1.2.13. Sleep survey or evaluation2. Key Clinical Issues; 2.1. Energy Metabolism; 2.1.1. Glucose; 2.1.2. Fructose; 2.1.3. Protein metabolism in diabetes; 2.1.4. Fat metabolism; 2.2. Autonomic Neuropathy; 2.3. Immune Dysregulation and Increased Permeability; 2.4. Maldigestion; 2.4.1. Reflux; 2.4.2. Dyspepsia; 2.4.3. Dysbiosis; 2.4.4. Malabsorption; 2.4.5. Delayed gastric emptying; 2.5. Autacoids: Profound Biochemical Effects; 3. Diagnoses and Comorbidities; 3.1. Prevalent Comorbidities; 3.1.1. Vascular sequella and neurodegeneration; 3.1.2. Hyperlipidemia and hypertension 3.1.3. Kidney disease |
| Record Nr. | UNINA-9910817439903321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | 1 online resource (801 p.) |
| Disciplina | 613.2 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Gastrointestinal system - Diseases - Nutritional aspects
Liver - Diseases - Nutritional aspects Bioactive compounds |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-71646-1
0-12-397764-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease; Copyright; Contents; Preface: Liver and Gastrointestinal Health; Contributors; Chapter 1: The Alkaline Way in Digestive Health; 1. Dietary Factors in Metabolism; 1.1. Profile: Metabolic Acidosis as a Major Cause of Chronic Disease; 1.1.1. Associated signs and symptoms; 1.1.1.1 Fatigue; 1.1.1.2 Osteopenia and osteoporosis; 1.1.2. Relevant evaluations; 1.1.2.1 Self-evaluation: Testing for pH; 1.1.2.2 Laboratory evaluation: Reducing immune reactivity; 1.1.3. Clinical interventions: the alkaline way
1.1.3.1 Alkaline diet1.1.3.1.1. Enhancing immune defenses; 1.1.3.1.2. Buffering cellular chemistry; 1.1.3.2 Alkaline nutrients; 1.1.3.2.1. Buffering minerals; 1.1.3.2.2. Buffering fats; 1.1.4. Individual essential nutritional supplementation; 1.1.4.1 Antioxidants: Ascorbate to zinc; 1.1.4.2 B-complex vitamins to support methylation; 2. Glycemic Load as a Tool for Better Digestive andCardiovascular Management; 2.1. Associated Signs and Symptoms; 2.2. Self-evaluation; 2.2.1. Glycemic index: Older and less useful; 2.2.2. Glycemic load: Newer and more useful 2.3. Intervention: Low to Moderate Glycemic Diet3. Native Whey-Based Meals and Gastrointestinal Health; 4. Food Allergies and Sensitivities; 4.1. Associated Signs and Symptoms; 4.1.1. The link between allergies and digestive competence; 4.1.2. Lactose intolerance; 4.1.3. Gluten or casein intolerance or sensitivity; 4.2. Evaluation: LRA by ELISA/ACT Tests; 4.3. Intervention: Hypoallergenic Diet; 5. The Role of Specific Nutrients in Digestive Health; 6. Conclusion; References; Relevant Websites; Chapter 2: Functional Assessment of Gastrointestinal Health; 1. Physiology of Digestion 2. Clinical Issues in Digestive Health2.1. Profile: Dysbiosis; 2.1.1. Associated signs and symptoms; 2.1.2. Etiology; 2.1.2.1 Sidebar: initial probiotic research; 2.1.3 Intervention: probiotic supplementation; 2.1.3.1 Benefits of microflora; 2.1.3.1.1. Production of digestive enzymes by microflora; 2.1.3.1.2. Reduced lipid levels; 2.1.3.1.3. Inhibition of pathogens; 2.1.3.2 Probiotic dosage; 2.1.3.2.1. Preventive applications; 2.1.3.2.2. Therapeutic interventions; 2.1.3.2.3. Medical probiotics; 2.2. Profile: Hyperpermiability (Leaky Gut Syndrome); 2.2.1. Associated signs and symptoms 2.2.2. Intervention: recycled glutamine supplementation2.3. Profile: Allergic Reactions as a Cause and Effect of Leaky Gut; 2.3.1. Hyperpermeability as a cause of reactivity; 2.3.2. Allergies as a cause of hyperpermeability; 2.4. Profile: Maldigestion and Enteropathy; 2.4.1. Comorbidities; 2.4.2. Cause and Consequences; 2.4.2.1 Low enzyme levels; 2.4.2.2 Poorly timed gastric emptying; 2.4.2.3 Surgical restructuring of the GI tract; 2.4.2.4 Malabsorption; 2.4.2.5 Enteropathy; 2.5. Transit Time; 2.5.1. Associated signs and symptoms; 2.5.1.1 Delayed transit time; 2.5.1.2 Rapid transit time 2.5.2. Evaluation: self-test for transit time |
| Record Nr. | UNINA-9910462230003321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
